Related Experiment Video
Updated: Oct 4, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
The expression, function, and utilization of Protamine1: a literature review
Shengnan Ren1, Xuebo Chen2, Xiaofeng Tian1
1Department of Breast, Thyroid, Hepatobiliary and Pancreatic Surgery, Xinmin Division of China-Japan Union Hospital of Jilin University, Changchun, China.
Protamine 1 (PRM1), crucial for fertilization, is also a cancer testis antigen. Research highlights its roles in spermatogenesis, cancer, and nanomedicine, suggesting therapeutic potential.
Area of Science:
- Spermatogenesis and reproductive biology
- Oncology and cancer immunology
- Biotechnology and nanomedicine
Background:
- Protamine 1 (PRM1) is an arginine-rich protein essential for sperm function and male fertility.
- Abnormal PRM1 expression is linked to infertility and it functions in diverse cellular processes.
- PRM1 is recognized as a cancer testis antigen (CTA) in chronic leukemia and colorectal cancer.
Purpose of the Study:
- To review the expression and function of Protamine 1 (PRM1) in spermatogenesis.
- To explore the potential of PRM1 in cancer treatment and nanomedicine.
- To provide insights for future PRM1-based therapeutic strategies.
Main Methods:
- Comprehensive literature search using PubMed with keywords 'protamine 1', 'PRM1', or 'P1'.
- Inclusion of articles published from January 1, 1980, to July 20, 2021.
- Additional data gathered by screening reference lists of identified articles.
Main Results:
- PRM1 is highly conserved and plays critical roles in spermatogenesis.
- PRM1 exhibits diverse biological functions beyond reproduction, including roles in tumorigenesis.
- PRM1's identification as a CTA in certain cancers is noted.
Conclusions:
- Protamine 1 (PRM1) is extensively studied in male infertility.
- Further research into PRM1 could lead to its development as a novel tumor marker.
- PRM1 holds promise as a drug delivery vector with significant clinical implications.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Depolarizing Blockers: Pharmocokinetics
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Parenteral Anesthetics: Overview

